Payal Rabde, a Healthcare Industry Expert, highlights that the chlamydia infection diagnostics market has reached USD 874.26 million in 2026 and is on track to reach USD 1,580.46 million by 2035, advancing at a CAGR of 6.80%. Key chlamydia infection diagnostics market companies shaping the market include Hologic, Roche Diagnostics, BD, Abbott while major growth segments span test type, infection type, setting, end user, region.